AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 FEB 6 - (NewsRx.com & NewsRx.net) -- Researchers have established a new murine model that improves the study of ovarian cancer.
"Vascular endothelial growth factor (VEGF) performs multifaceted functions in the tumor microenvironment promoting angiogenesis, suppressing antitumor immune response, and possibly exerting autocrine functions on tumor cells. However, appropriate syngeneic animal models for in vivo studies are lacking. Using retroviral transfection and fluorescence-activated cell sorting, we generated a C57BL6 murine ovarian carcinoma cell line that stably overexpresses the murine VEGF164 isoform and the enhanced green fluorescent protein," reported researchers from the United States.
"VEGF164 overexpression dramatically accelerated tumor growth and ascites formation, significantly enhanced tumor angiogenesis, and substantially promoted the survival of tumor cells in vivo. In vitro, VEGF164 overexpression significantly enhanced cell survival after growth factor withdrawal and conferred resistance to apoptosis induced by cisplatin through an autocrine mechanism," noted L. Zhang and colleagues, University of Pennsylvania, Center for Research on Reproduction and Women's Health.
"VEGF/green fluorescent protein-expressing tumors were not recognized by the adaptive immune system. After vaccination, a ...
Source: HighBeam Research, New murine model enables study of growth factor in gynecological...